SureTrader Stock Hero Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

CTD Holdings Inc. (CTDH)

Add CTDH Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 5/21/2015 8:47:32 PM - Followers: 91 - Board type: Free - Posts Today: 0





CTD Holdings, Inc.

14120 NW 126th Terrace
Alachua, FL 32615

Phone: 386-418-8060

 & &




Company Info:


CTD Holdings, Inc. engages in the marketing and sale of cyclodextrins and related products. The company develops cyclodextrins-based applications in stabilization of flavors for food products; preparation of antifungal complexes for foods and toiletries; elimination of undesirable tastes and odors; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability, and storability of foods. It also manufactures selected cyclodextrin complexes, as well as distributes cyclodextrins. CTD Holdings sell cyclodextrins, the molecules that bring oil and water together for applications in the areas of agriculture, analytical chemistry, biotechnology, cosmetics, diagnostics, electronics, foodstuffs, pharmaceuticals, and toxic waste treatment. In addition, the company provides consulting services for the commercialization of new products containing cyclodextrins, as well as sells own manufactured and licensed products containing cyclodextrins. It serves chemical supply houses, pharmaceutical companies, diagnostics companies, and food companies for research and development. The company was founded in 1990 and is based in High Springs, Florida.



Share Structure:


As of March 3, 2014:

100,000,000  Shares Authorized

48,562,355 Issued and Outstanding
Source:  March 3, 2014 10-K Filing

Insider Holdings - April 14, 2014
r  and (Page 8)
33,187,647 (19,837,647 accounted for on SEC Form 4s - - CE Rick Strattan

Public Float Estimated Float (April 14, 2014):
15,374,708 (31.65%)




YouTube Videos - Great updates regularly released directly from CTD Holdings:

CTD Holdings September 2014 Update Video
September 25, 2014 -

CTD Holdings August 2014 Update Video
August 21, 2014 -

CTD Holdings July 2014 Update Video
July 31, 2014 -

CTD Holding June 2014 Update Video
June 21, 2014 -

CTD Holdings May 2014 Update Video
May 22, 2014 -

CTD Holdings April 2014 Update Video
April 22, 2014 -

CTD Holdings March 2014 Update Video
March 14, 2014 -

CTD Holdings Private Placement Update
February 21, 2014 -

CTD Holdings February 2014 Update Video
February 18, 2014 -

CTD Holdings January 2104 Update Video
January 21, 2014 -

CTD Holdings December 2013 Update Video
December 21, 2014 -

Older Update Videos Available at:

Dr. Tate has been consistanly posted monthly update videos since 2010.  Great way to see the history of this company.


DD Links:

CTD Holdings Fact Sheet
March 31, 2012 -

WSR Equity Research Report
February 21, 2012 -

CTD Holdings - Nanosonic Uses USDA Grant to Install Solar Energy System
October 19, 2011 -

FDA Orphan Drug Status Designation - Trappsol
May 17, 2010 -

Dateline Story on Addi & Cassi Hempel - Using Trappsol to Treat Niemann Pick Type C
January 5, 201
0 -

Cyclodextrin As A Therapeutic "Drug" For HIV AIDS, Niemann Pick Type C and other Viruses

April 16th, 2009 -


Mentioned in a Wall Street Journal Article:


Cyclodextrin - Wikipedia:


CEO Rick Strattan - Personally thanked following FDA Approval:


Trappsol Google Search Results:


Cyclodextrin in the News:



 What is a Cyclodextrin?

CDs are molecules that bring together oil and water and have potential applications anywhere oil and water must be used together. Successful applications have been made in the areas of agriculture, analytical chemistry, biotechnology, cosmetics, diagnostics, electronics, foodstuffs, pharmaceuticals and toxic waste treatment. Stabilization of food flavors and fragrances is the largest current worldwide market for CD applications. We and others have developed CD-based applications in stabilization of flavors for food products; elimination of undesirable tastes and odors; preparation of antifungal complexes for foods and toiletries; stabilization of fragrances and dyes; reduction of foaming in foods; cosmetics and toiletries; and the improvement of quality, stability and storability of foods.

CDs can improve the solubility and stability of a wide range of drugs. Many promising drug compounds are unusable or have serious side effects because they are either too unstable or too insoluble in water. Strategies for administering currently approved compounds involve injection of formulations requiring pH adjustment and/or the use of organic solvents. The result is frequently painful, irritating, or damaging to the patient. These side effects can be ameliorated by CDs. CDs also have many potential uses in drug delivery for topical applications to the eyes and skin.
We believe the application of CDs in both over the counter (OTC) and ethical ophthalmic products provides the quickest path to market for the introduction of preparations containing CDs for topical drug use.

Cyclodextrin Market:

CDs have been used in a variety of food products in Japan for over 25 years. In 1999, the economic impact of CDs on the Japanese economy was reported to be $2.6 billion. Within the last 10 years, many more European countries have approved the use of CDs in food products. In the United States, major starch companies are renewing their earlier interest in CDs as food additives. We believe the food additive industry world-wide will continue to increase its use of CDs.
Natural CDs have been confirmed to be generally recognized as safe ("GRAS") in most of the world, now including the U.S. Moreover, recent approvals of products containing CDs by the U.S. Food and Drug Administration ("FDA") suggest that regulatory approval for new products may be easier in the future. In 2001, Janssen Pharmaceutica, now a subsidiary of Johnson & Johnson, received FDA approval to market Sporanox®, an antifungal which contained hydroxypropyl BCD. In 2008, one of our clients used our product, Trappsol® HPB, in an FDA approved compassionate use clinical trial for the treatment of Niemann Pick Type C disease. We now sell this product under our Trappsol® product line as "Cyclo™."  Our customer applied to the FDA to designate Trappsol® Cyclo™ as an orphan drug in the treatment of Niemann Pick Type C disease.  Under the Orphan Drug Act, companies that develop a drug for a disorder affecting fewer than 200,000 people in the United States may seek designation as an orphan drug and, if such application is approved, they have the ability to sell it without competition for seven years, and may get clinical trial tax incentives.  On May 17, 2010, the FDA designated Trappsol® Cyclo™ as an orphan drug for the treatment of Niemann Pick Type C (NPC) disease.
Applications of CDs in personal products and for industrial uses have appeared in many patents and patent applications. Procter & Gamble uses CDs in Bounce®, a popular fabric softener and Febreze®. Avon uses CDs in its dermal preparations using its Age Protective System (APS®). The prices of the natural CDs have decreased enough so that use of these materials will be more price competitive.





Name: C.E. Rick Strattan
Job Title: President and CEO
Phone: (386) 454-0887 ext. 22
Fax: (386) 454-8134

Name: George Fails
Job Title: Director of Field Operations
Phone: (386) 454-0887
Fax: (386) 454-8134

Name: Dr. Jeffrey Tate
Job Title: President/ CEO Nanosonic Products
Phone: (386) 418-8060

Board of Directors:



Latest News Releases:

July 22, 2014:
CTD Holding Closes $1.725 Million Private Placement

July 9, 2014:
CTD Holdings Names New Chief Executive

May 22, 2014
CTD Holdings Appoints N. Scott Fine Vice Chairman and Lead Director

May 14, 2014
CTD Holdings Reports Strong Product Sales and Acquires Equity Capital in First Quarter

April 16, 2014
CTD Holdings, Inc. Closes on Securities Purchase and Collaboration Agreement

March 11, 2014
CTD Holdins Reports Record Revenues for 2013

February 20, 2014
CTD Holdings, Inc. Closes on Private Placement





Company Filings:






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTDH News: Quarterly Report (10-q) 05/15/2015 04:23:09 PM
CTDH News: Annual Report (10-k) 03/27/2015 05:36:20 PM
CTDH News: Statement of Changes in Beneficial Ownership (4) 02/17/2015 04:21:48 PM
CTDH News: Statement of Changes in Beneficial Ownership (4) 02/17/2015 04:20:38 PM
CTDH News: Statement of Changes in Beneficial Ownership (4) 02/17/2015 04:19:27 PM
#4947   Thanks, I have 25,000 shares and my goal JellyDonut 05/21/15 08:47:32 PM
#4946   Hi Jelly I haven't been here in a PrepTillUdie 05/21/15 01:39:41 PM
#4945   Maybe .25 today then? And, yes, I will JellyDonut 05/20/15 06:04:02 AM
#4944   Ok, so I was talking about the options Lazarus 05/19/15 11:31:08 AM
#4943   So it should be .25 then? But wait, JellyDonut 05/18/15 04:09:49 PM
#4942   Whats the good news. I just looked Lazarus 05/18/15 11:10:48 AM
#4941   Yup good news. Not the sign of a JellyDonut 05/18/15 09:31:41 AM
#4940   News today. Very good person added to scientific was16 05/04/15 03:43:55 PM
#4939   Why the lol? Lazarus 04/28/15 10:17:57 AM
#4938   News: .25? Lol JellyDonut 04/28/15 07:43:56 AM
#4937   We hit .25 yet? JellyDonut 04/23/15 03:20:38 PM
#4936   I miss the videos. John Bates 04/23/15 11:50:00 AM
#4935   Not crazy about a two hundred and fifty floored 04/22/15 09:47:27 PM
#4934   I never said 25 cents. You heard Lazarus 04/20/15 01:09:29 PM
#4933   $2.00 short term, not .25. JellyDonut 04/18/15 07:14:01 AM
#4932   The song "Hey Jood" by kozuh 04/18/15 04:39:57 AM
#4931   carpe diem ... CTDH ... !!! kozuh 04/18/15 04:32:43 AM
#4930   Guys, CTDH just went up 28% !!!! kozuh 04/18/15 04:26:30 AM
#4929   If the shoe fits....... JellyDonut 04/14/15 06:05:53 AM
#4928   You seem to imply that I said the Lazarus 04/13/15 01:54:01 PM
#4927   .60, darn, missed my shot at .25 lmfao! JellyDonut 04/10/15 03:06:48 PM
#4926   And you would know, just ask yourself. Lmfao JellyDonut 04/10/15 05:24:34 AM
#4925   My spelling might be off but my logic Lazarus 04/10/15 02:45:18 AM
#4924   Your spelling cracks me up. Please spell correctly JellyDonut 04/09/15 11:59:01 AM
#4923   lol... dood, you crack me up! '' Lazarus 04/09/15 11:18:03 AM
#4922   Among the other huge advantages CTDH has, they JellyDonut 04/09/15 11:13:56 AM
#4921   RE: This technique is PATENTABLE Lazarus 04/09/15 10:56:44 AM
#4920   You had me at World's only pharmacudecle floored 04/09/15 09:52:07 AM
#4919   Updated Presentation: JellyDonut 04/09/15 05:58:01 AM
#4918   Advantage, CTDH: ALACHUA, FL -- (Marketwired) -- 04/07/15 -- JellyDonut 04/09/15 05:40:24 AM
#4917   And? JellyDonut 04/09/15 05:35:03 AM
#4916   Well let's see now..... Lazarus 04/09/15 12:39:23 AM
#4915   Charts do have meaning in all stocks but floored 04/08/15 11:17:37 PM
#4914   Charts on penny stocks don't mean much. JellyDonut 04/08/15 07:59:36 PM
#4913   I dont have a clue as to what Lazarus 04/08/15 07:48:25 PM
#4912   He forgot more than you will ever know JellyDonut 04/08/15 03:42:38 PM
#4911   You're not showing it. And it looks like JellyDonut 04/08/15 03:41:45 PM
#4910   If the warrants have not been exercised, its dark knight 04/08/15 12:34:58 PM
#4908   Yous sound so much more like Jeremiah - ksuave 04/08/15 09:19:04 AM
#4907   Soon enough? I see you continue to speak JellyDonut 04/08/15 06:03:39 AM
#4906   WTF??? Do you read the filings? Lazarus 04/08/15 01:38:59 AM
#4905   Are you that seller, Lazarus? ksuave 04/07/15 09:42:13 PM
#4904   I think we'll know soon enuf. Lazarus 04/07/15 08:25:21 PM
#4903   That's a personal financial question. What do you think? JellyDonut 04/07/15 07:04:25 PM
#4902   What's stopping you??? Lazarus 04/07/15 06:12:34 PM
#4901   News out today was16 04/07/15 02:57:15 PM
#4900   Can't wait to buy more at these levels, JellyDonut 04/07/15 02:30:13 PM
#4899   Register for Webinar on Cyclodextrin for NPC Lazarus 04/07/15 11:55:06 AM
#4898   CTD Holdings used to get their raw product Lazarus 04/06/15 05:37:00 PM
#4897   A positive note would be CTD's top spot Lazarus 04/06/15 05:30:29 PM